PathoGenetix Garners $10,000,000 Series C Financing Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    12 Gill Street Woburn, MA 01801
  • Company Description
    PathoGenetix has pioneered commercial applications of single molecule DNA, RNA and protein analysis. The company’s innovative technologies address high value unmet needs in bio-security, human diagnostics, and food and drug contaminant monitoring. Addressable segments of these markets where the company’s technology offers compelling advantage approach $4.0 billion.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series C
  • Proceeds Purposes
    Proceeds purposes will be used to fund continued efforts to commercialize its Genome Sequence Scanning (GSS) technology.
  • M&A Terms
  • Venture Investor
    Ascension Health Ventures
  • Venture Investor
    HealthCare Ventures
  • Venture Investor
    Excel Venture Management
  • Venture Investor
    Excel Venture Management

Trending on Xconomy